ArticleThe journal of allergy and clinical immunology. Global2026
Dupilumab opens a therapeutic window in food protein-induced enterocolitis syndrome by unlicensing dendritic cells.
Matthew Plassmeyer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.